Fri, June 30, 2023

Rebecca Liang Downgraded (BGNE) to Hold and Decreased Target to $196 on, Jun 30th, 2023

Rebecca Liang of Bernstein, Downgraded "BeiGene, Ltd." (BGNE) to Hold and Decreased Target from $335 to $196 on, Jun 30th, 2023.

Rebecca has made no other calls on BGNE in the last 4 months.



There are 4 other peers that have a rating on BGNE. Out of the 4 peers that are also analyzing BGNE, 1 agrees with Rebecca's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Li of "B of A Securities" Maintained at Hold with Increased Target to $263 on, Wednesday, April 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Rebecca


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $321 on, Tuesday, February 28th, 2023
  • Michael Schmidt of "Guggenheim" Reiterated at Strong Buy and Held Target at $350 on, Tuesday, February 28th, 2023
  • Yaron Weber of "Cowen & Co." Maintained at Buy with Increased Target to $262 on, Tuesday, February 28th, 2023